Physician profile
Blake Hale
NPI 1346736022
$14,388.47
in general payments reported to CMS, 2019-2025
20 companies · $2,610 in 2025
The $2,610 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,052 · 2020: $1,089 · 2021: $2,371 · 2022: $1,112 · 2023: $1,544 · 2024: $2,611 · 2025: $2,610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,489 · Food and Beverage: $2,176 · Consulting Fee: $2,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,489.42 |
| Food and Beverage | $2,175.99 |
| Consulting Fee | $2,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,406.91 | 2019-2025 | Prophecy, Invision, Inbone |
| Depuy Synthes Sales INC. | $3,439.92 | 2021-2025 | Na, Motoband, Hammerlock |
| Medical Device Business Services, INC. | $1,285.92 | 2024 | |
| Orthofix Medical, INC. | $808.96 | 2019-2021 | |
| Organogenesis INC. | $735.25 | 2019-2023 | Puraply |
| Musculoskeletal Transplant Foundation INC. | $652.60 | 2019 | |
| Zimmer Biomet Holdings, INC. | $597.68 | 2019-2022 | |
| Integra Lifesciences Corporation | $383.00 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Tenex Health INC. | $249.70 | 2020 | |
| Wright Medical Technology, INC. | $157.11 | 2019-2020 | |
| Medline Industries LP | $144.08 | 2021 | |
| Bioventus LLC | $137.13 | 2019 | |
| Bone Support INC. | $102.16 | 2019 | |
| Kci USA, INC. | $95.62 | 2020 | |
| Smith+Nephew, INC. | $62.24 | 2021-2024 | Q-Fix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $59.00 | 2019 | |
| In2bones USA, LLC | $23.32 | 2022 | |
| Derma Sciences, INC. | $18.77 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.99 | 2025 | Exparel |
| Baudax Bio INC. | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Hale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.